ARHGDIB anticorps (AA 1-201)
Aperçu rapide pour ARHGDIB anticorps (AA 1-201) (ABIN559945)
Antigène
Voir toutes ARHGDIB AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 1-201
-
Fonction
- Mouse polyclonal antibody raised against a full-length recombinant ARHGDIB.
-
Séquence
- MTEKAPEPHV EEDDDDELDS KLNYKPPPQK SLKELQEMDK DDESLIKYKK TLLGDGPVVT DPKAPNVVVT RLTLVCESAP GPITMDLTGD LEALKKETIV LKEGSEYRVK IHFKVNRDIV SGLKYVQHTY RTGVKVDKAT FMVGSYGPRP EEYEFLTPVE EAPKGMLARG TYHNKSFFTD DDKQDHLSWE WNLSIKKEWT E
-
Réactivité croisée
- Humain
-
Attributs du produit
- Antibody Reactive Against Recombinant Protein.
-
Immunogène
- ARHGDIB (AAH09200, 1 a.a. ~ 201 a.a) full-length recombinant protein with GST tag.
-
-
-
-
Indications d'application
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- 50 % glycerol
-
Conseil sur la manipulation
- Aliquot to avoid repeated freezing and thawing.
-
Stock
- -20 °C
-
Stockage commentaire
- Store at -20°C or lower. Aliquot to avoid repeated freezing and thawing.
-
-
-
: "RhoGDI2 is associated with HGF-mediated tumor invasion through VEGF in stomach cancer." dans: Clinical & experimental metastasis, Vol. 31, Issue 7, pp. 805-15, (2014) (PubMed).
: "Comparative proteomics analysis of Barrett metaplasia and esophageal adenocarcinoma using two-dimensional liquid mass mapping." dans: Molecular & cellular proteomics : MCP, Vol. 6, Issue 6, pp. 987-99, (2007) (PubMed).
-
: "RhoGDI2 is associated with HGF-mediated tumor invasion through VEGF in stomach cancer." dans: Clinical & experimental metastasis, Vol. 31, Issue 7, pp. 805-15, (2014) (PubMed).
-
- ARHGDIB (rho GDP Dissociation Inhibitor (GDI) beta (ARHGDIB))
-
Autre désignation
- ARHGDIB
-
Sujet
-
Full Gene Name: Rho GDP dissociation inhibitor (GDI) beta
Synonyms: D4,GDIA2,GDID4,LYGDI,Ly-GDI,RAP1GN1,RhoGDI2 -
ID gène
- 397
-
Pathways
- Caspase Cascade in Apoptosis
Antigène
-